Screener
Vir Biotechnology, Inc. VIR Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s operating margin?
- Vir Biotechnology, Inc. (VIR) reported operating margin of -92.4% in Q2 2026.
- How has Vir Biotechnology, Inc.'s operating margin changed year-over-year?
- Vir Biotechnology, Inc.'s operating margin increased by 97.1% year-over-year, from -3,191.7% to -92.4%.
- What is the long-term trend for Vir Biotechnology, Inc.'s operating margin?
- Over 4 years (2020 to 2025), Vir Biotechnology, Inc.'s operating margin has grown at a 15.8% compound annual growth rate (CAGR), from -388.9% to -699.2%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Vir Biotechnology, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude